In mUICC stage II HCC, patients with high EV‐LINC00853 expression had lower overall survival rate than those with low EV‐LINC00853 expression (Fig. 6, HR = 16.55, 95% CI = 1.52–179.7, log‐rank P = 0.021). The gene discussed is LINC00853; the disease is hepatocellular carcinoma.